Potential of porous poly-D,L-lactide-co-glycolide particles as a carrier for recombinant human bone morphogenetic protein-2 during osteoinduction in vivo

被引:0
|
作者
Boyan, BD
Lohmann, CH
Somers, A
Niederauer, GG
Wozney, JM
Dean, DD
Carnes, DL
Schwartz, Z
机构
[1] Univ Texas, Hlth Sci Ctr, Dept Orthopaed, San Antonio, TX 78284 USA
[2] Univ Texas, Hlth Sci Ctr, Dept Periodont, San Antonio, TX 78284 USA
[3] Univ Texas, Hlth Sci Ctr, Dept Biochem, San Antonio, TX 78284 USA
[4] OsteoBiol Inc, San Antonio, TX USA
[5] Genet Inst, Andover, MA USA
[6] Univ Texas, Hlth Sci Ctr, Dept Endodont, San Antonio, TX 78284 USA
[7] Hebrew Univ Jerusalem, Dept Periodont, Jerusalem, Israel
来源
关键词
recombinant human bone morphogenetic protein-2; osteoinduction; bone graft substitute; poly-D; L-lactide-co-glycolide copolymer; bone morphogenetic protein carrier;
D O I
10.1002/(SICI)1097-4636(199907)46:1<51::AID-JBM6>3.3.CO;2-9
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Several different biodegradable bone graft materials are in clinical or preclinical use for the repair of bone defects in orthopedics, maxillofacial surgery, and periodontics. This study tested the hypothesis that poly-D,L-lactide-co-glycolide copolymer (PLG) can be used as an effective carrier of recombinant human bone morphogenetic protein-2 (rhBMP-2) and that the composite has osteoinductive ability. Porous PLG rods were shredded to a particle size ranging from 250 to 850 mu m Active and inactive demineralized freeze-dried bone allografts (DFDBA) with a comparable particle size were used as positive and negative controls, respectively. PLG particles were treated with vehicle or with 5 or 20 mu g rhBMP-2. DFDBA and PLG particles were placed in gelatin capsules, mixed with vehicle or rhBMP-2, and implanted at intramuscular sites in male Nu/Nu (nude) mice. Each mouse underwent bilateral implantation with implants of the same formulation, resulting in five groups of four mice per group: active DFDBA, inactive DFDBA, PLG, PLG + 5 mu g rhBMP-2, and PLG + 20 mu g rhBMP-2. After 56 days, the implants were recovered and processed for histology. Bone induction was assessed by use of a semiquantitative scoring system based on the amount of new bone formed in representative histological sections. Histomorphometry was also used to measure the area of new bone formed and the area of residual implant material. The results showed that active DFDBA induced the formation of ossicles containing new bone with bone marrowlike tissue, whereas inactive DFDBA or PLG particles alone did not induce new bone. The addition of rhBMP-2 to PLG particles resulted in new bone formation that had a greater bone induction score than active DFDBA. Moreover, the histomorphometric analysis showed that the addition of rhBMP-2 to PLG particles induced the formation of a greater area of new bone and bone marrowlike tissue than active DFDBA. The resorption of the PLG particles was markedly increased with the addition of rhBMP-2, suggesting that rhBMP-2 may attract and regulate resorptive cells at the implantation site. The results of the present study indicate that PLG copolymers are good carriers for BMP and promote the induction of new bone formation. Further, the PLG copolymers with rhBMP-2 had a greater effect in inducing new bone formation and resorbing the implanted material than active DFDBA alone. (C) 1999 John Wiley & Sons, Inc.
引用
收藏
页码:51 / 59
页数:9
相关论文
共 50 条
  • [1] Potential of porous poly-D,L-lactide-co-glycolide particles as a carrier for recombinant human bone morphogenetic protein-2 during osteoinduction in vivo
    Department of Orthopaedics, Univ. of Texas Health Science Center, 7703 Floyd Curl Drive, San Antonio, TX 78284-7774, United States
    不详
    不详
    不详
    不详
    不详
    不详
    J. Biomed. Mater. Res., 1 (51-59):
  • [2] Clonazepam microencapsulation in poly-D,L-lactide-co-glycolide microspheres
    Benelli, P
    Conti, B
    Genta, I
    Costantini, M
    Montanari, L
    JOURNAL OF MICROENCAPSULATION, 1998, 15 (04) : 431 - 443
  • [3] Biphasic calcium phosphate coated with poly-D,L-lactide-co-glycolide biomaterial as a bone substitute
    Ignjatovic, Nenad
    Ninkov, Petar
    Ajdukovic, Zorica
    Vasijevic-Radovic, Dana
    Uskokovic, Dragan
    JOURNAL OF THE EUROPEAN CERAMIC SOCIETY, 2007, 27 (2-3) : 1589 - 1594
  • [4] Expression of bone morphogenetic protein in the course of osteoinduction by recombinant human bone morphogenetic protein-2
    Okubo, Y
    Bessho, K
    Fujimura, K
    Kusumoto, K
    Ogawa, Y
    Iizuka, T
    CLINICAL ORAL IMPLANTS RESEARCH, 2002, 13 (01) : 80 - 85
  • [5] Experimental studies on bone induction using low-molecular-weight poly (DL-lactide-co-glycolide) as a carrier for recombinant human bone morphogenetic protein-2
    Bessho, K
    Carnes, DL
    Cavin, R
    Ong, JL
    JOURNAL OF BIOMEDICAL MATERIALS RESEARCH, 2002, 61 (01): : 61 - 65
  • [6] Effect of elcatonin on osteoinduction by recombinant human bone morphogenetic protein-2
    Okubo, Y
    Bessho, K
    Fujimura, K
    Kusumoto, K
    Ogawa, Y
    Iizuka, T
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 269 (02) : 317 - 321
  • [7] Bone morphogenetic protein-2 loaded poly(D, L-lactide-co-glycolide) microspheres enhance osteogenic potential of gelatin/hydroxyapatite/β-tricalcium phosphate cryogel composite for alveolar ridge augmentation
    Chang, Hao-Chieh
    Yang, Connie
    Feng, Fang
    Lin, Feng-Huei
    Wang, Chi-Hwa
    Chang, Po-Chun
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2017, 116 (12) : 973 - 981
  • [8] Degradation behaviour in vitro for poly(D,L-lactide-co-glycolide) as drug carrier
    Lee, JS
    Chae, GS
    Kim, MS
    Cho, SH
    Lee, HB
    Khang, G
    BIO-MEDICAL MATERIALS AND ENGINEERING, 2004, 14 (02) : 185 - 192
  • [9] Measurement of protein diffusion through poly(D,L-lactide-co-glycolide)
    Fredenberg, S
    Reslow, M
    Axelsson, A
    PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY, 2005, 10 (02) : 299 - 307
  • [10] Encapsulation of Protein Drug using Electrosprayed Porous Poly(D,L-lactide-co-glycolide) Microparticles
    Paik, D.
    Choi, S.
    TISSUE ENGINEERING PART A, 2015, 21 : S409 - S409